C2W-27388-42596
3 vaccinations
7 coded responses
30 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 900 / CA
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-17
Dose 1 — Moderna
-
2021-01-22
Registered in v-safe
-
2021-01-22
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Good · Site: PainFree text: Bruising at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-24
- 2021-02-01
- 2021-02-07
-
2021-02-14
Dose 2 — Moderna
- 2021-02-14
-
2021-02-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · Muscle or body aches, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-02-17
Survey response — days 1–6 daily, dose 2MedDRA: Muscle spasms, Pain in extremity, Rash pruritic, Tenderness — Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteFree text: Rash is located on the same arm as injection site, but approx 5 inches away on bicep. Rash in approx 1 in wide X 4 in long, slightly itchy, sensitive to light touch and painful when pressed. Mild cramping in bicep.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Survey response — days 1–6 daily, dose 2MedDRA: Pruritus, Rash — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Rash is fading but itchiness worseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-19
Survey response — days 1–6 daily, dose 2MedDRA: Pruritus, Rash — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Rash on bicep is fading and less itchyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-21
- 2021-02-28
- 2021-03-08
- 2021-03-14
- 2021-03-22
- 2021-03-28
-
2021-05-16
Survey response — 3 months, dose 2MedDRA: Muscle strain, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Lower back strain (I think unrelated) · Healthcare visit (other): Made PT appointment, have not visited yetMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-16
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-15
-
2021-12-08
Dose 3 — Moderna
-
2021-12-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Nausea, Diarrhea · Be unable to work or attend schoolAdult check-in
-
2021-12-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-12
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-12-13
- 2021-12-14
- 2021-12-17
- 2021-12-22
-
2021-12-29
Survey response — day 21, dose 3MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: GoodFree text: Had cold symptoms for 2 days, COVID tests came back negativeMedDRA releases: 2024-11 · check-in free text available
- 2022-01-07
- 2022-01-12
-
2022-03-09
Survey response — 3 months, dose 3MedDRA: Eczema, Pre-existing disease, Urticaria — Feeling: GoodFree text: Hives/increased eczemaMedDRA releases: 2024-11 · check-in free text available
-
2022-05-11
Call successfulNot applicable - Accidental Reporting
- 2022-06-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-17 | Moderna | |
| 2 | 2021-02-14 | Moderna | |
| 3 | 2021-12-08 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Bruising at injection site
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Rash is located on the same arm as injection site, but approx 5 inches away on bicep. Rash in approx 1 in wide X 4 in long, slightly itchy, sensitive to light touch and painful when pressed. Mild cramping in bicep.
Systemic reaction (other): Rash is fading but itchiness worse
Systemic reaction (other): Rash on bicep is fading and less itchy
Release 8 — 3 months, dose 2
Symptoms: Lower back strain (I think unrelated)
Healthcare visit (other): Made PT appointment, have not visited yet
Release 10 — day 21, dose 3
Symptoms: Had cold symptoms for 2 days, COVID tests came back negative
Release 11 — 3 months, dose 3
Symptoms: Hives/increased eczema
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Eczema | · | · | ✓ |
| SD | Muscle strain | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Muscle spasms | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Rash pruritic | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release